Skip to main content

Lance Wilkes

Analyst

Bernstein

Equibles does not estimate personal net worth.

About Lance Wilkes

Lance Wilkes is recorded as Analyst at Bernstein. Lance Wilkes has spoken on 23 earnings calls across 8 companies, most recently for Molina Healthcare, Inc. on October 22, 2026. Those appearances were for Elevance Health, Inc. (ELV), Molina Healthcare, Inc. (MOH), Humana Inc (HUM), Centene Corp (CNC), Unitedhealth Group Inc (UNH) and 3 other companies. The companies whose calls Lance Wilkes spoke on are classified in the Healthcare sector.

Lance Wilkes on recent calls

“Could you talk a little bit about puts and takes with respect to 3Q MCR, in particular, and Medicaid? I'm just interested in if the acuity shift hit all represented in 3Q MLR and how prior period development impacted 3Q. Thanks.”
Analyst — Bernstein, Molina Healthcare Announces Third Quarter 2026 Earnings Release and Conference Call Dates ·
“Could you talk a little bit about 27 selling season, in particular, interested in Carillon services and how much of the outlook and growth might come from internal shifts of contracts as opposed to external, and then maybe related to 27, if you could talk a little on, for employers, second blue bid, and if you want to…”
Analyst — Bernstein, Elevance Health 2026 Q3 Earnings Call ·
“Could you talk a little bit about value-based care and looking at it from the two ways you can look at it from a contracting perspective if you could just give a little perspective on the trend differences you see fee-for-service contracting versus the some of the positive things you're seeing with your value-based…”
Analyst — Bernstein, 2Q 2026 Humana Inc. Earnings Conference Call ·
“Can you talk a little bit about your ICRA business and, in particular, kind of size and membership, sales outlook, margin performance, and the types of clients that are interested in that thus far?”
Analyst — Bernstein, CENTENE CORPORATION SECOND QUARTER 2026 EARNINGS ·
“Can you talk a little bit about G&A and your G&A leverage going forward? In particular, interested in understanding as I'm looking at things like 27, 28, how much of the benefits and scale leverage are you expecting to come from just purely holding the line on G&A as opposed to being able to reduce G&A?”
Analyst — Bernstein, Molina Healthcare’s Second Quarter 2026 Earnings Conference Call ·

Affiliation history

  • Bernstein

    Analyst

    Source not stated

    Current

Company network

Recent activity

Show 11 earlier activities